{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:49:55Z","timestamp":1780325395677,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.lfs.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T20:27:21Z","timestamp":1484598441000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress"],"prefix":"10.1016","volume":"171","author":[{"given":"Luiz K.S.","family":"Kanazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora D.","family":"Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eti\u00e9li M.","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palloma de A.S.","family":"Hocayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Paulo S.","family":"Beir\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela L.","family":"de M\u00e9lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francislaine A.","family":"dos Reis L\u00edvero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Rita","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"Stipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Acco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.lfs.2017.01.007_bb0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1517\/17460441.2013.804057","article-title":"Novel routes to bipolar disorder drug discovery","volume":"8","author":"Hoertel","year":"2013","journal-title":"Expert Opin. Drug Discovery"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2017.01.007_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: a meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2017.01.007_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0006-3223(00)00929-X","article-title":"Signaling: cellular insights into the pathophysiology of bipolar disorder","volume":"48","author":"Manji","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-013-3397-x","article-title":"Tamoxifen use for the management of mania: a review of current preclinical evidence","volume":"231","author":"Armani","year":"2014","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.lfs.2017.01.007_bb0035","first-page":"326","article-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00442810","article-title":"Lithium inhibition of protein kinase C activation-induced serotonin release","volume":"99","author":"Wang","year":"1989","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2017.01.007_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-5618.2012.01046.x","article-title":"Effects of alpha-lipoic acid in an animal model of mania induced by d-amphetamine","volume":"14","author":"Mac\u00eado","year":"2012","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu031","article-title":"Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania","volume":"18","author":"Abrial","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2017.01.007_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejphar.2012.10.018","article-title":"Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice","volume":"698","author":"Mines","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2011.06.012","article-title":"Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphene","volume":"500","author":"Pereira","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1734-1140(11)70399-1","article-title":"Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania","volume":"63","author":"Barbosa","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2017.01.007_bb0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/fcp.12022","article-title":"The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels","volume":"27","author":"Tonelli","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12011-014-0067-8","article-title":"Combination of omega-3 fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania","volume":"160","author":"Arunagiri","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.lfs.2017.01.007_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2016.03.013","article-title":"Antimanic-like effects of (R)-(\u2212)-carvone and (S)-(+)-carvone in mice","volume":"619","author":"Nogoceke","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2017.01.007_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2016.06.044","article-title":"Lithium and valproate prevent methylphenidate-induced mania-like behaviors in the hole board test","volume":"629","author":"Souza","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2017.01.007_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuint.2015.07.002","article-title":"Quercetin in brain diseases: potential and limits","volume":"89","author":"Dajas","year":"2015","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-3623(98)00220-1","article-title":"Flavonoids and the inhibition of PKC and PI 3-kinase","volume":"32","author":"Gamet-Payrastre","year":"1999","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.lfs.2017.01.007_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2016.07.027","article-title":"Quercetin reduces manic-like behavior and brain oxidative stress induced by paradoxical sleep deprivation in mice","volume":"99","author":"Kanazawa","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clnu.2011.01.010","article-title":"Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis","volume":"30","author":"Boots","year":"2011","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.lfs.2017.01.007_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.pnpbp.2010.04.025","article-title":"Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice","volume":"34","author":"Bhutada","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.lfs.2017.01.007_bb0120","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.pnpbp.2008.09.023","article-title":"The antimanic-like effect of tamoxifen: behavioral comparison with other PKC-inhibiting and antiestrogenic drugs","volume":"32","author":"Sabioni","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-4328(00)00318-1","article-title":"Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice","volume":"118","author":"Gould","year":"2001","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0003-2697(92)90122-N","article-title":"Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein","volume":"202","author":"Jiang","year":"1992","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2017.01.007_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881106060241","article-title":"Modelling facets of mania: new directions related to the notion of endophenotypes","volume":"20","author":"Einat","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pnpbp.2003.10.015","article-title":"Perspectives for the development of animal models of bipolar disorder","volume":"28","author":"Machado-Vieira","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00429209","article-title":"Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes","volume":"73","author":"Huey","year":"1981","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.lfs.2017.01.007_bb0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00431272","article-title":"Dopamine and mania: behavioural and biochemical effects of the dopamine receptor blocker pimozide","volume":"67","author":"Post","year":"1980","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2017.01.007_bb0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF01273357","article-title":"Adaptive changes in the rat dopaminergic transmission following repeated lithium administration","volume":"103","author":"Dziedzicka-Wasylewska","year":"1996","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426687","article-title":"Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man","volume":"53","author":"Smith","year":"1977","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00429209","article-title":"Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes","volume":"73","author":"Huey","year":"1981","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0253-7613.75678","article-title":"Methylphenidate-induced mania-like symptoms","volume":"43","author":"Chakraborty","year":"2011","journal-title":"Indian J. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.9758\/cpn.2016.14.3.314","article-title":"Manic symptoms due to methylphenidate use in an adolescent with traumatic brain injury","volume":"14","author":"Ekinci","year":"2016","journal-title":"Clinical Psychopharmacology and Neuroscience."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(00)00264-8","article-title":"Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration","volume":"398","author":"Burrows","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0195","first-page":"166","article-title":"Role of caffeine in lithium treated methylphenidate induced oxidative stress in an animal model of mania","volume":"3","author":"Shanthakumar","year":"2013","journal-title":"Asian Journal of Pharmaceutical Sciences."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2017.01.007_bb0210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pnpbp.2013.01.007","article-title":"Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania","volume":"43","author":"Mac\u00eado","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.lfs.2017.01.007_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpsychires.2010.05.011","article-title":"Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania","volume":"45","author":"Jornada","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10571-008-9343-5","article-title":"Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain","volume":"29","author":"Bhalla","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2017.01.007_bb0225","first-page":"2014","article-title":"Lipid peroxidation in psychiatric illness: overview of clinical evidence","volume":"828702","author":"Joshi","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.007_bb0230","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.neuroscience.2006.11.010","article-title":"Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate","volume":"144","author":"Cui","year":"2007","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.lfs.2017.01.007_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum 100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"Journal of Pyschiatric Research."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","article-title":"Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects","volume":"421","author":"Machado-Vieira","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2006.01.004","article-title":"Methylphenidate treatment induces oxidative stress in young rat brain","volume":"1078","author":"Martins","year":"2006","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/j.lfs.2017.01.007_bb0250","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s00213-013-3413-1","article-title":"Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?","volume":"231","author":"Pereira","year":"2014","journal-title":"Psychopharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2017.01.007_bb0255","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1016\/S0924-977X(13)70564-9","article-title":"Myricitrin, a PKC inhibitor, exerts antimanic-like effects in animal models","volume":"23","author":"Andreatini","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2017.01.007_bb0260","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0006-3223(93)90006-Y","article-title":"Altered platelet protein kinase C activity in bipolar affective disorder, manic episode","volume":"33","author":"Friedman","year":"1993","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.lfs.2017.01.007_bb0265","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.108.147959","article-title":"Protein kinase C beta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice","volume":"328","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.lfs.2017.01.007_bb0270","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2017.01.007_bb0275","article-title":"Tamoxifen and amphetamine abuse: are there therapeutic possibilities?","author":"Mikelman","year":"2016","journal-title":"J. Chem. Neuroanat."},{"issue":"6","key":"10.1016\/j.lfs.2017.01.007_bb0280","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson's disease","volume":"129","author":"Segura-Aguilla","year":"2014","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.lfs.2017.01.007_bb0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11011-013-9473-4","article-title":"Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration","volume":"29","author":"Model","year":"2014","journal-title":"Metab. Brain Dis."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517300073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517300073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T09:06:28Z","timestamp":1566464788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517300073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":57,"alternative-id":["S0024320517300073"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.01.007","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}